Publications by authors named "Alexander Mathioudakis"

Background: Community-acquired pneumonia (CAP) is a frequent and potentially life-threatening condition. Even though the disease is common, evidence on CAP management is often of variable quality. This may be reinforced by the lack of a systematic and homogeneous way of defining the disease in randomised controlled trials (RCTs).

View Article and Find Full Text PDF
Article Synopsis
  • - The development of the CompOsite iNdexes For Response in asthMa (CONFiRM) aimed to create patient-centered tools that measure responses to biologics for severe asthma in both adults and children, integrating clinical data and quality of life (QoL) indicators.
  • - Experts and patients collaborated to identify significant outcome changes and devised CONFiRM scores, which demonstrated high levels of agreement on key factors, with patients emphasizing the importance of quality of life more than healthcare professionals did.
  • - The CONFiRM scores effectively measure treatment response, with strong validity metrics indicating their reliability, and they facilitate a comprehensive assessment of biologics’ effectiveness; further studies are required for prospective validation.
View Article and Find Full Text PDF
Article Synopsis
  • A study compared the effects of extra-fine particle inhaled corticosteroids (ICS) to standard particle size ICS on patients with chronic obstructive pulmonary disease (COPD) from 2010 to 2017, focusing on exacerbations needing hospitalization and overall mortality rates.
  • Of the nearly 40,500 patients analyzed, the results showed that extra-fine particle ICS did not significantly lower the risk of hospitalizations or all-cause mortality compared to standard ICS; however, a subgroup of patients using pressurized metered dose inhalers (pMDIs) did report reduced risks.
  • The findings suggest that while extra-fine particle ICS may not generally offer protective benefits, they could be beneficial for specific patients
View Article and Find Full Text PDF
Article Synopsis
  • There are conflicting findings on the effectiveness of steroids for treating severe community-acquired pneumonia (CAP), with past studies having small sample sizes.
  • Recent large trials, ESCAPe and CAPE COD, evaluated different steroid treatments and timing, with ESCAPe not showing any significant difference in mortality, while CAPE COD found hydrocortisone improved short-term survival and reduced complications.
  • Differences in study design, including patient characteristics and steroid regimens, highlight the need for further research to establish the best dosing and long-term effects of steroid use in severe CAP.
View Article and Find Full Text PDF

Background: Chronic obstructive pulmonary disease (COPD) and asthma can be treated with inhaled corticosteroids (ICS) delivered by low climate impact inhalers (dry powder inhalers) or high climate impact inhalers (pressurized metered-dose inhalers containing potent greenhouse gasses). ICS delivered with greenhouse gasses is prescribed ubiquitously and frequent despite limited evidence of superior effect. Our aim was to examine the beneficial and harmful events of ICS delivered by low and high climate impact inhalers in patients with asthma and COPD.

View Article and Find Full Text PDF

Rationale: Long-acting muscarinic antagonists (LAMAs) reduce the risk of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), usually taken once daily in the morning. However, the circadian activity of autonomic regulation suggests that the highest need for anticholinergic therapy may be in the late night/early morning. This is supported by evidence that AECOPD most often begins in the morning.

View Article and Find Full Text PDF
Article Synopsis
  • Pulmonary alveolar proteinosis (PAP) is a rare lung syndrome characterized by the accumulation of proteinaceous material, leading to symptoms like progressive dyspnea and hypoxemia, with various diagnostic methods such as CT scans, bronchoalveolar lavage, and genetic testing suggested for evaluation.
  • A European Respiratory Society Task Force, comprised of diverse experts, developed evidence-based guidelines for diagnosing and managing PAP using a systematic review of literature and the GRADE approach for assessing the strength of recommendations.
  • The Task Force provided specific management recommendations, including whole lung lavage, GM-CSF therapy, and potential treatments like rituximab, alongside diagnostic approaches involving GM-CSF antibody
View Article and Find Full Text PDF

Background And Objective: The Grading of Recommendations, Assessment, Development and Evaluations (GRADE)-ADOLOPMENT methodology has been widely used to adopt, adapt, or de novo develop recommendations from existing or new guideline and evidence synthesis efforts. The objective of this guidance is to refine the operationalization for applying GRADE-ADOLOPMENT.

Methods: Through iterative discussions, online meetings, and email communications, the GRADE-ADOLOPMENT project group drafted the updated guidance.

View Article and Find Full Text PDF

Background: The varied treatment response to inhaled corticosteroids (ICS) in patients with COPD and the associated increased risk of pneumonia necessitate a personalized ICS therapeutic approach. This is informed by blood eosinophil count (BEC), which predicts ICS treatment response. However, BEC appears to change in response to ICS treatment.

View Article and Find Full Text PDF

Background: Ventilator-associated pneumonia (VAP) is a prevalent and grave hospital-acquired infection that affects mechanically ventilated patients. Diverse diagnostic criteria can significantly affect VAP research by complicating the identification and management of the condition, which may also impact clinical management.

Objectives: We conducted this review to assess the diagnostic criteria and the definitions of the term "ventilator-associated" used in randomised controlled trials (RCTs) of VAP management.

View Article and Find Full Text PDF

Tree nut allergy is a lifelong and potentially life-threatening condition. The standard of care is strictly avoiding the culprit nut and treating accidental reactions symptomatically. To evaluate potential therapeutic options for desensitizing patients with IgE-mediated tree nut allergy, we systematically searched three bibliographic databases for studies published until January 2024.

View Article and Find Full Text PDF

Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more.

View Article and Find Full Text PDF
Article Synopsis
  • Early career and senior members of Assembly 5 discussed significant recent findings related to airway diseases from the European Respiratory Society International Congress 2023 in Milan.
  • The focus of the presentations included asthma, COPD, chronic cough, and bronchiectasis, underscoring the relevance of these conditions.
  • A total of 739 abstracts were submitted, mostly by early career researchers, reflecting a growing interest in airway diseases within the scientific community.
View Article and Find Full Text PDF

This meta-analysis compares the efficacy and safety of inhaled systemic corticosteroids for COPD exacerbations.Following a pre-registered protocol, we appraised eligible randomised controlled trials (RCTs) according to Cochrane methodology, performed random-effects meta-analyses for all outcomes prioritised in the European Respiratory Society COPD core outcome set and rated the certainty of evidence as per Grading of Recommendations Assessment, Development and Evaluation methodology.We included 20 RCTs totalling 2140 participants with moderate or severe exacerbations.

View Article and Find Full Text PDF

Background: Smoking poses the most common risk factor for chronic obstructive pulmonary disease (COPD) and aggravates disease progression. Tobacco dependence inhibits smoking cessation and may affect smoking patterns that increase tobacco exposure and predispose to lung function decline.

Aims And Objectives: We aimed to assess tobacco dependence in current smokers with and without COPD and evaluate its role in disease development.

View Article and Find Full Text PDF

Introduction: Population pharmacokinetic studies of β-lactam antimicrobials in critically ill patients derive models that inform their dosing. In non-linear mixed-effects modelling, covariates are often used to improve model fit and explain variability. We aimed to investigate which covariates are most commonly assessed and which are found to be significant, along with global patterns of publication.

View Article and Find Full Text PDF

Introduction: Viruses are detected in over 50% of acute asthma attacks and in a notable proportion of patients with asthma during stable disease state They are associated with worse outcomes. We will conduct a series of systematic reviews and meta-analyses to quantify the prevalence and clinical burden of various respiratory viruses in stable asthma and acute asthma attacks. In addition, we will assess the viral loads of respiratory viruses during stable and acute asthma, to explore whether viral load could differentiate attacks triggered by viruses versus those where viruses are present as "innocent bystanders".

View Article and Find Full Text PDF

Background: Approximately 10% of the global population identify themselves as penicillin allergic, yet 90% are not truly allergic and could safely tolerate penicillin. There is no simple way to identify these people. Current in vitro diagnostics include specific immunoglobulin E (with a sensitivity of 19% and specificity of 97%) and a basophil activation test (BAT) with undefined sensitivity and specificity.

View Article and Find Full Text PDF

Objectives: To inform clinical practice guidelines, randomized controlled trials (RCTs) of the management of pneumonia need to address the outcomes that are most important to patients and health professionals using consistent instruments, to enable results to be compared, contrasted, and combined as appropriate. This systematic review describes the outcomes reported in clinical trials of pneumonia management and the instruments used to measure these outcomes.

Study Design And Setting: Based on a prospective protocol, we searched MEDLINE/PubMed, Cochrane CENTRAL and clinical trial registries for ongoing or completed clinical trials evaluating pneumonia management in adults in any clinical setting.

View Article and Find Full Text PDF

Only a few therapies have been shown to prolong survival in specific patients with COPD. In recent years, the IMPACT and the ETHOS trials suggested that triple therapy (a combination of inhaled corticosteroid (ICS), long-acting muscarinic antagonist (LAMA) and long-acting β-agonist (LABA) given in a single inhaler) may reduce mortality compared with dual bronchodilation. These results need however to be interpreted with caution.

View Article and Find Full Text PDF
Article Synopsis
  • The field of pharmacological management for airway obstructive diseases, like asthma and COPD, is rapidly progressing with new insights into disease mechanisms and drug action pathways.
  • A seminar held by the European Respiratory Society in Naples covered advancements in drug therapies, steroid resistance, comorbidities, and potential biomarkers for prognosis and treatment.
  • Discussions also included the development of new drug targets, pharmacogenomics, biosimilars, and relevant regulations from the European Medicines Agency.
View Article and Find Full Text PDF

Combined pulmonary fibrosis and emphysema (CPFE) is a clinical syndrome characterized by upper lobe emphysema and lower lobe fibrosis manifested by exercise hypoxemia, normal lung volumes, and severe reduction of diffusion capacity of carbon monoxide. It has varying prevalence worldwide with a male predominance, and with smoking history of more than 40 pack-years being a common risk factor. The unique imaging features of CPFE emphasize its distinct entity, aiding in the timely detection of pulmonary hypertension and lung cancer, both of which are common complications.

View Article and Find Full Text PDF
Article Synopsis
  • * The ERS Congress 2022 included over 3000 abstract presentations, symposia, and skills workshops from all 14 assemblies, highlighting advancements in respiratory research.
  • * Key findings and insights from the Congress, particularly in airway diseases, asthma, COPD, and chronic cough, were reviewed by experts and Early Career Members to share recent developments in the field.
View Article and Find Full Text PDF

Importance: Childhood asthma control largely depends on rigorous and regular monitoring. Although various clinical parameters, biomarkers, and patient-reported outcomes are helpful for monitoring purposes, there is no consensus on the minimum and/or optimal set of parameters and their relative priority.

Objective: To assess actual and perceived optimal childhood asthma monitoring practices used globally.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Alexander Mathioudakis"

  • - Alexander Mathioudakis focuses his recent research on the implications of inhaled medications and corticosteroids in chronic respiratory conditions, examining aspects such as particle size in patients with COPD and the efficacy of various inhaler types in relation to environmental impact.
  • - His studies also delve into the management of severe community-acquired pneumonia, evaluating the role of steroid treatments, as well as providing a comprehensive analysis of diagnostic criteria for ventilator-associated pneumonia and tree nut allergy management.
  • - Mathioudakis is engaged in advancing clinical guidelines and recommendations, including those for asthma monitoring in children and the application of GRADE-ADOLOPMENT methodology to ensure relevant evidence-based practices are adopted in clinical settings.